Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-14 3:57 pm Purchase | 2025-06-30 | 13G | Bicara Therapeutics Inc. Common Stock BCAX | Vestal Point Capital LP | 5,000,000 9.200% | 2,231,025 (+80.57%) | Filing History |
| 2025-07-31 2:56 pm Purchase | 2025-06-30 | 13G | Bicara Therapeutics Inc. Common Stock BCAX | Invus Public Equities, L.P. | 5,216,969 9.600% | 2,144,142 (+69.78%) | Filing History |
| 2025-07-17 11:11 am Purchase | 2025-07-10 | 13G | Bicara Therapeutics Inc. Common Stock BCAX | FMR LLC | 2,756,217 5.100% | 217,813 (+8.58%) | Filing History |
| 2025-07-17 11:08 am Sale | 2025-06-30 | 13G | Bicara Therapeutics Inc. Common Stock BCAX | FMR LLC | 2,538,404 4.700% | -1,073,169 (-29.71%) | Filing History |
| 2025-05-15 4:13 pm Purchase | 2025-03-31 | 13G | Bicara Therapeutics Inc. Common Stock BCAX | Vestal Point Capital LP | 2,768,975 5.100% | 2,768,975 (New Position) | Filing History |
| 2025-05-12 10:28 am Purchase | 2025-03-31 | 13G | Bicara Therapeutics Inc. Common Stock BCAX | FMR LLC | 3,611,573 6.600% | 807,766 (+28.81%) | Filing History |
| 2025-03-03 09:14 am Purchase | 2025-02-24 | 13G | Bicara Therapeutics Inc. Common Stock BCAX | FMR LLC | 2,803,807 5.200% | 686,719 (+32.44%) | Filing History |
| 2025-02-12 09:16 am Sale | 2024-12-31 | 13G | Bicara Therapeutics Inc. Common Stock BCAX | FMR LLC | 2,117,088 3.900% | -378,245 (-15.16%) | Filing History |
| 2024-09-26 4:30 pm Purchase | 2024-09-16 | 13G | Bicara Therapeutics Inc. Common Stock BCAX | Invus Public Equities, L.P. | 3,072,827 5.700% | 3,072,827 (New Position) | Filing History |
| 2024-09-26 4:16 pm Purchase | 2024-09-16 | 13G | Bicara Therapeutics Inc. Common Stock BCAX | Red Tree GP, LLC | 3,170,509 5.800% | 3,170,509 (New Position) | Filing History |
| 2024-09-23 4:17 pm Purchase | 2024-09-16 | 13D | Bicara Therapeutics Inc. Common Stock BCAX | RA Capital Management, L.P. | 6,955,993 12.800% | 6,955,993 (New Position) | Filing History |
| 2024-09-18 5:10 pm Purchase | 2024-09-16 | 13D | Bicara Therapeutics Inc. Common Stock BCAX | TPG GP A LLC | 3,010,425 5.500% | 3,010,425 (New Position) | Filing History |
| 2024-09-18 11:57 am Purchase | 2024-09-18 | 13G | Bicara Therapeutics Inc. Common Stock BCAX | FMR LLC | 2,495,333 5.095% | 2,495,333 (New Position) | Filing History |